CAR T Cell Receptor Immunotherapy for Patients With B-cell Lymphoma

Clinical trial NCT00924326 · COMPLETED

Trial details

NCT number: NCT00924326
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Primary Mediastinal B-cell Lymphoma Diffuse, Large B-cell Lymphoma Diffuse Large B-Cell Lymphoma Transformed From Follicular Lymphoma Mantle Cell

Start date: 2009-02-17
Primary completion: 2015-09-30
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.